Sonit Handa

Sonit Handa, MD, MS, MBA, is a seasoned professional with extensive experience in medical affairs, commercial strategy, and regulatory operations within the pharmaceutical industry. Currently serving as Senior Director of Strategic Planning & Operations for Global Rare Disease at Amgen, Sonit previously held key leadership roles at Horizon, Astellas Pharma, and Deloitte, focusing on international expansion, commercial transformation, and strategic operations. With a solid foundation in medicine and engineering, evidenced by degrees from B. J. Medical College, Duke University, and The University of Memphis, Sonit has demonstrated expertise in driving product launches, enhancing market access, and fostering organizational excellence across multiple regions and therapeutic areas.